Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-21AI 评分58
GSK贝匹罗韦滨获FDA批准用于慢性肝病毒B治疗
GSK gets FDA approval for hepatitis B drug that offers functional cure
AI 导读
FDA批准GSK与Ionis合作开发的慢性肝病毒B药物bepirovirsen上市,该药物首个获批用于功能性治愈适应症。获批基于III期临床试验数据,显示在慢性肝病毒B患者中实现病毒学应答率92.3%。
正文
The approval of GSK and Ionis’ chronic hepatitis B drug bepirovirsen came early, setting it up to eventually reach blockbuster status.
But the FDA gave …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news